CYCS and cancer: Notably, HK2’s interaction with VDAC helps maintain MMP and inhibits the release of apoptotic factors such as cytochrome c. Additionally, dysregulation of HK2 function has been linked to glycolysis inhibition and induction of mitophagy, further emphasizing its role in cancer cell survival and metabolism.